Bank Hapoalim BM’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Sell |
3,948
-95
| -2% | -$8.35K | 0.05% | 101 |
|
|
2025
Q1 | $368K | Sell |
4,043
-100
| -2% | -$9.1K | 0.05% | 101 |
|
|
2024
Q4 | $357K | Sell |
4,143
-43,797
| -91% | -$3.77M | 0.06% | 110 |
|
|
2024
Q3 | $4.56M | Sell |
47,940
-750
| -2% | -$71.3K | 0.69% | 43 |
|
|
2024
Q2 | $4.45M | Buy |
48,690
+7,978
| +20% | +$730K | 0.63% | 45 |
|
|
2024
Q1 | $3.69M | Buy |
40,712
+35,339
| +658% | +$3.21M | 0.48% | 52 |
|
|
2023
Q4 | $437K | Sell |
5,373
-290
| -5% | -$23.6K | 0.06% | 119 |
|
|
2023
Q3 | $452K | Sell |
5,663
-6,810
| -55% | -$544K | 0.07% | 107 |
|
|
2023
Q2 | $982K | Sell |
12,473
-779
| -6% | -$61.3K | 0.14% | 101 |
|
|
2023
Q1 | $1.03M | Sell |
13,252
-1,723
| -12% | -$134K | 0.14% | 102 |
|
|
2022
Q4 | $1.16M | Buy |
14,975
+1,726
| +13% | +$134K | 0.15% | 94 |
|
|
2022
Q3 | $891K | Buy |
13,249
+739
| +6% | +$49.7K | 0.11% | 108 |
|
|
2022
Q2 | $961K | Buy |
12,510
+1,449
| +13% | +$111K | 0.12% | 114 |
|
|
2022
Q1 | $882K | Buy |
11,061
+2,105
| +24% | +$168K | 0.09% | 136 |
|
|
2021
Q4 | $689K | Buy |
+8,956
| New | +$689K | 0.07% | 150 |
|
|
2020
Q3 | – | Sell |
-7,297
| Closed | -$454K | – | 193 |
|
|
2020
Q2 | $454K | Buy |
7,297
+1,590
| +28% | +$98.9K | 0.11% | 118 |
|
|
2020
Q1 | $310K | Sell |
5,707
-1,818
| -24% | -$98.8K | 0.1% | 131 |
|
|
2019
Q4 | $483K | Buy |
+7,525
| New | +$483K | 0.11% | 111 |
|
|
2016
Q2 | – | Sell |
-3,489
| Closed | -$201K | – | 189 |
|
|
2016
Q1 | $201K | Hold |
3,489
| – | – | 0.05% | 152 |
|
|
2015
Q4 | $228K | Hold |
3,489
| – | – | 0.05% | 148 |
|
|
2015
Q3 | $220K | Buy |
+3,489
| New | +$220K | 0.05% | 144 |
|